JP Morgan Maintains Overweight on Progyny, Lowers Price Target to $57
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Anne Samuel maintains an Overweight rating on Progyny (NASDAQ:PGNY) but lowers the price target from $58 to $57.
October 09, 2023 | 6:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan maintains an Overweight rating on Progyny but lowers the price target from $58 to $57.
The news is directly related to Progyny (PGNY). JP Morgan's decision to maintain an Overweight rating indicates a positive outlook for the company. However, the lowering of the price target from $58 to $57 might create a slight negative sentiment among investors, potentially impacting the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100